Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_assertion type Assertion NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_head.
- NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_assertion wasGeneratedBy ECO_0000203 NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_provenance.
- NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_assertion wasDerivedFrom befree-20140225 NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_provenance.
- NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_assertion SIO_000772 23255822 NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_provenance.
- NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_assertion evidence source_evidence_literature NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_provenance.
- NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_assertion description "[In contrast, APOE ε4 carriers had reduced [(18)F]FDG uptake in occipital cortex (p < 0.05) and a borderline significant effect in posterior cingulate (p = 0.07) in a dose-dependent manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301069.RAfERt8lJywi8BSyDNF4LGbcGe7vTMLZLUYUkL3XnkSd4130_provenance.